期刊文献+

C5a/C5aR通路在硕大利什曼原虫易感小鼠免疫病理发生中的作用及其机制

Role of C5a/C5aR pathway in immunopathogenesis of mice susceptible to L. major infection and its mechanism
下载PDF
导出
摘要 目的研究C5a/C5aR通路在对硕大利什曼原虫(Leishmania major,L.major)易感的BALB/c小鼠免疫病理发生中的作用及机制探讨。方法以C5aR KO小鼠(BALB/c背景)为模型,观察比较了WT和C5aR KO的BALB/c小鼠在L.major感染后的病变情况,有限稀释法检测了各组感染小鼠体内寄生虫的负荷,并进一步通过FACS检测了相关细胞因子如IL-17和IL-4的产生,来探讨C5a/C5aR通路在L.major易感型BALB/c小鼠免疫病理发生中的作用机制。结果相比WT小鼠,C5aRKO小鼠感染L.major后的病变程度明显减轻(P<0.05),体内寄生虫负荷也显著降低(6.952±0.398vs 4.340±0.434,P<0.01);同时,FACS胞内染色结果表明CD4+IL-4+T细胞亚群百分比显著降低(0.960 0±0.148 3 vs0.314 0±0.042 6,P<0.01),但CD3+IL-17+T细胞亚群的百分比在两组之间无显著差异(0.792 0±0.051 3 vs 0.858 0±0.084 5,P=0.522 3)。结论 C5a/C5aR通路通过调节Th2细胞关键细胞因子IL-4的产生,在L.major易感小鼠的免疫病理发生中发挥作用。 Objective To study the role of C5a/C5aR pathway in immunopathogenesis of mice susceptible to Leishmania major (L. major) infection, and to investigate its mechanism. Methods C5aR knock out (KO) BALB/c mice were used as animal models, and wild type (WT) BALB/c mice were used as controls. Development and progress of footpad lesion was monitored weekly by measuring the lesion size after infection. Parasites proliferation in vivo was quantified by limiting dilution analysis. Levels of Th2 cells subpopulation related eytokine IL-4 and proinflammatory cytokine IL-17 were measured by FACS. Results Compared with WT mice, C5aR KO mice became highly resistant to L. major infection as their lesion degree ( P 〈 0.05 ) and parasites load were both significantly reduced (6. 952 ± 0. 398 vs 4. 340 ± 0.434, P 〈 0.01 ). The percentage of CD4 ± IL-4 * T cell subset in the C5aR KO mice was significantly lower than that in the WT mice (0. 960 0 ±0. 148 3 vs O. 314 0 ± 0. 042 6, P 〈 0.01 ), but there was no significant difference between the percentages of CD3 + IL-17 + T cell subset in C5aR KO mice and WT mice (0. 792 0 ±0.051 3 vs O. 858 0 ± 0.084 5, P = 0. 5223). Conclusion C5a/C5aR pathway plays a critical role in regulation of mice suscepti- ble to L. major infection via promoting IL-4 production.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第3期219-222,共4页 Journal of Third Military Medical University
基金 重庆市自然科学基金面上项目(CSTC2008BB5021) 教育部归国人员启动基金(2009)~~
关键词 C5a/C5aR 硕大利什曼原虫 白细胞介素4 免疫病理 CSa/CSaR Leishmania major IL-d immunopathogenesis
  • 相关文献

参考文献17

  • 1Mougneau E, Bihl F, Glaichenhaus N. Cell biology and immunology of Leishmania[ J]. Immunol Rev, 2011,240( 1 ) : 286 - 296.
  • 2Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice [ J ]. Nat Rev Immunol, 2002, 2 ( 11 ) : 845 - 858.
  • 3Jayakumar A, Widenmaier R, Ma X, et al. Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp. -infected macro- phages[ J]. J Parasitol, 2008, 94 ( 1 ) : 84 - 93.
  • 4Ray M, Gam A A, Boykins R A, et al. Inhibition of interferon-gamma signaling by Leishmania donovani [ J]. J Infect Dis, 2000, 181 ( 3 ) : 1121 - 1128.
  • 5Lopez-Kostka S, Dinges S, Griewank K, et al. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice[ J]. J Immunol, 2009, 182(5) : 3039 -3046.
  • 6Mosser D M, Brittingham A. Leishmania, macrophages and complement: a tale of subversion and exploitation [ J ]. Parasitology, 1997, 115 Suppl: S9-S23.
  • 7Carter C R, Whitcomb J P, Campbell J A, et al. Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice[J]. Infect lmmun, 2009,77(12) : 5668 -5675.
  • 8Olivier M, Gregory D J, Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view[J]. Clin Microbiol Rev, 2005, 18(2) : 293 -305.
  • 9Guo R F, Ward P A. Role of C5a in inflammatory responses[J]. Annu Rcv lmmunol, 2005, 23 : 821 - 852.
  • 10Xu G, Liu D, Okwor I, et al. LIGHT is critical for IL-12 production by dendritic cells, optimal CD4 + Thl cell response, and resistance to Leishmania major[ J ]. J Immunol, 2007, 179 (10) : 6901 - 6909.

二级参考文献20

  • 1Amar A P, Levy M L. Palhogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury [ J ]. Neurosurgery, 1999, 44(5) : 1027 -1040.
  • 2Hausmann O N. Post-traumatic inflammation following spinal cord injury [J]. Spinal Cord, 21303, 41(7): 369-378.
  • 3Kwan B K, Tetzlaff W, Grauer J N, et al. Pathophysiology and pharmacologic treatment of acute spinal cord injury[J]. Spine J, 2004, 4(4): 451 -464.
  • 4Guo R F, Ward P A. Role of C5a in inflammatory responses[J]. Annu Rev Immunol, 2005, 23:821 -852.
  • 5Klos A, Tenner A J, Johswich K O, et al. The role of the anaphylatoxins in health and disease[J]. Mol Immunol, 2009, 46(14) : 2753 -2766.
  • 6Lee H, Whitfeld P L, Mackay C R. Receptors for complement C5a. The importance of CSaR and the enigmatic role of CSL2[J]. Immunol Cell Biol, 2008, 86(2): 153-160.
  • 7Ricklin D, Lambris J D. Complement-targeted therapeutics [ J ]. Nat Biotechnol, 2007, 25(11): 1265-1275.
  • 8Plemel J R, Duncan G, Chen K W, et al. A graded forceps crush spinal cord injury model in mice[J]. J Neurotrauma, 2008, 25(4) : 350 -370.
  • 9Finch A M, Wong A K, Paczkowski N J, et al. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a[J]. J Med Chem, 1999, 42(11) : 1965 -1974.
  • 10Bracken M B, Shepard M J, Collins W F, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second national acute spinal cord injury study [J]. N Engl J Med, 1990, 322(20): 1405 -1411.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部